The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery

Paediatric Anaesthesia

Volumn 23, Issue 11, 2013, Pages 1035-1041

  Gertler, Ralph ^a   Martin, Klaus ^a   Hapfelmeier, Alexander ^b   Tassani Prell, Peter ^a   Braun, Siegmund ^a   Wiesner, Gunther ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

coagulation blood; congenital heart disease cardiac; surgery cardiac; transfusion hematology

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FRESH FROZEN PLASMA; PROTAMINE;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHEST TUBE; CHEST TUBE DRAINAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOSIS; ENZYME ACTIVITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECONSTITUTED BLOOD PRIME; THORAX DRAINAGE; THROMBOCYTE COUNT;

COAGULATION - BLOOD; CONGENITAL HEART DISEASE - CARDIAC; SURGERY - CARDIAC; TRANSFUSION - HEMATOLOGY;

ANESTHESIA, GENERAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHEST TUBES; CYANOSIS; DRAINAGE; FACTOR XIII; FEMALE; FIBRINOGEN; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT;

EID: 84885185638     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12193     Document Type: Article

References (34)

1. Robbins KC,. A study on the conversion of fibrinogen to fibrin. Am J Physiol Am Physiological Soc 1944; 142: 581-588.
2. Lorand L, Urayama T, Atencio AC, et al,. Inheritance of deficiency of fibrin-stabilizing factor (factor 13). Am J Hum Genet Elsevier; 1970; 22: 89.
3. Anwar R, Gallivan L, Edmonds SD, et al,. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897-905.
4. Hedner U, Henriksson P, Nilsson IM,. Factor XIII in a clinical material. Scand J Haematol 2009; 14: 114-119.
5. Weber CF, Jambor C, Marquardt M, et al,. Thrombelastometric detection of factor XIII deficiency. Anaesthesist 2008; 57: 487-490.
6. Korte WC, Szadkowski C, Gähler A, et al,. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110: 239-245.
7. Levy JH, Gill R, Nussmeier NA, et al,. Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report. Thromb Haemost 2009; 102: 765-771.
8. Gödje O, Gallmeier U, Schelian M, et al,. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33.
9. Gerlach R,. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-1623.
10. Wettstein P, Haeberli A, Stutz M, et al,. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004; 99: 1564-1569.
11. Levin E, Wu J, Devine DV, et al,. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000; 83: 54-59.
12. Bockeria LA, Samsonova NN, Yurlov IA, et al,. Factor XIII deficiency after "open Heart" surgery in children: potential target for pharmacological therapy. 14th World Congress on Heart Disease. 2012.
13. Levy JH, Greenberg C,. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2012. doi: 10.1111/j.1537-2995.2012. 03865.x
14. ®). Thromb Haemost 2010; 104: 385-391.
15. Martin K, Gertler R, Liermann H, et al,. Switch from aprotinin to -aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery. Br J Anaesth 2011; 19: 107.
16. Gertler R, Wiesner G, Tassani-Prell P, et al,. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine? J Cardiothorac Vasc Anesth 2011; 25: 981-986.
17. Brody JI, Pickering NJ, Fink GB,. Concentrations of factor VIII-related antigen and factor XIII during open heart surgery. Transfusion 1986; 26: 478-480.
18. Eaton MP, Iannoli EM,. Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Pediatr Anesth 2011; 21: 31-42.
19. Haas T, Fries D, Velik-Salchner C, et al,. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008; 106: 1360-1365.
20. Haas T, Korte W, Spielmann N, et al,. Perioperative course of FXIII in children undergoing major surgery. Pediatr Anesth 2012; 22: 641-646.
21. Attard C, Cini C, Monagle P, et al,. The impact of Cardiopulmonary bypass on Factor XIII levels in children. Thromb Res Elsevier Ltd; 2012; 130: e238-e239.
22. McCall MM, Blackwell MM, Smyre JT, et al,. Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial. Ann Thorac Surg 2004; 77: 983-987.
23. Oliver WC, Beynen FM, Nuttall GA, et al,. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 2003; 75: 1506-1512.
24. Miller BE, Mochizuki T, Levy JH, et al,. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85: 1196-1202.
25. Henriksson P, Hedner U, Nilsson IM, et al,. Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant. Pediatr Res 1974; 8: 789-791.
26. Chandler WL, Patel MA, Gravelle L, et al,. Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagul Fibrinolysis 2001; 12: 101-108.
27. Schroth M, Meissner U, Cesnjevar R, et al,. Recombinant factor XIII reduces severe pleural effusion in Children after open-heart surgery. Pediatr Cardiol 2005; 27: 56-60.
28. Gerlach R, Raabe A, Zimmermann M, et al,. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000; 54: 260-264.
29. Gödje O, Haushofer M, Lamm P, et al,. The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg 1998; 46: 263-267.
30. Shainoff JR, Estafanous FG, Yared JP, et al,. Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108: 437-445.
31. Korte W,. F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol Elsevier Ltd; 2010; 24: 85-93.
32. Hsieh L, Nugent D,. Factor XIII deficiency. Haemophilia 2008; 14: 1190-1200.
33. Weber CF, Sanders JO, Friedrich K, et al,. Role of thrombelastometry for the monitoring of factor XIII. Hämostaseologie 2011; 31: 111-117.
34. Jambor C, Reul V, Schnider TW, et al,. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesth Analg 2009; 109: 1023-1028.